Recent advances in preoperative imaging of renal tumors

Current Opinion in Urology

Volumn 18, Issue 1, 2008, Pages 111-115

  Zhang, Jingbo ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Renal cancer; Renal cell carcinoma; Renal mass; Renal tumor

Indexed keywords

CARBONATE DEHYDRATASE IX; FLUORODEOXYGLUCOSE F 18; MONOCLONAL ANTIBODY; RADIOISOTOPE;

COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOGRAPHY; GROWTH RATE; HUMAN; ISOTOPE LABELING; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; KIDNEY TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; TARGET CELL; TUMOR BIOPSY; TUMOR DIFFERENTIATION; VOLUMETRY;

BIOPSY; DIAGNOSTIC IMAGING; HUMANS; KIDNEY; KIDNEY NEOPLASMS;

EID: 37348999175     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e3282f13a9b     Document Type: Review

References (45)

1. Reuter VE, Presti JC Jr. Contemporary approach to the classification of renal epithelial tumors. Semin Oncol 2000; 27:124-137.
2. Weiss LM, Gelb AB, Medeiros LJ. Adult renal epithelial neoplasms. Am J Clin Pathol 1995; 103:624-635.
3. Storkel S, van den Berg E. Morphological classification of renal cancer. World J Urol 1995; 13:153-158.
4. Russo P. Evolving understanding and surgical management of renal cortical tumors. Mayo Clin Proc 2000; 75:1233-1235.
5. Russo P. Localized renal cell carcinoma. Curr Treat Options Oncol 2001; 2:447-455.
6. Motzer RJ, Bacik J, Mariani T, et al. Treatment outcome and survival associated with metastatic renal cell carcinoma of nonclear-cell histology. J Clin Oncol 2002; 20:2376-2381.
7. Dechet CB, Zincke H, Sebo TJ, et al. Prospective analysis of computerized tomography and needle biopsy with permanent sectioning to determine the nature of solid renal masses in adults. J Urol 2003; 169:71-74.
8. Dechet CB, Sebo T, Farrow G, et al. Prospective analysis of intraoperative frozen needle biopsy of solid renal masses in adults. J Urol 1999; 162:1282-1284.
9. Lechevallier E, Andre M, Barriol D, et al. Fine-needle percutaneous biopsy of renal masses with helical CT guidance. Radiology 2000; 216:506-510.
10. Kauczor HU, Schwickert HC, Schweden F, et al. Bolus-enhanced renal spiral CT: technique, diagnostic value and drawbacks. Eur J Radiol 1994; 18:153-157.
11. Sheth S, Scatarige JC, Horton KM, et al. Current concepts in the diagnosis and management of renal cell carcinoma: role of multidetector CT and three-dimensional CT. Radiographics 2001; 21 (Spec No):S237-S254.
12. Schreyer HH, Uggowitzer MM, Ruppert-Kohlmayr A. Helical CT of the urinary organs. Eur Radiol 2002; 12:575-591.
13. Benjaminov O, Atri M, O'Malley M, et al. Enhancing component on CT to predict malignancy in cystic renal masses and interobserver agreement of different CT features. AJR Am J Roentgenol 2006; 186:665-672. The presence of either nodular or septal enhancement shows the highest sensitivity for predicting malignancy in cystic renal masses.
14. Herts BR, Coll DM, Novick AC, et al. Enhancement characteristics of papillary renal neoplasms revealed on triphasic helical CT of the kidneys. AJR Am J Roentgenol 2002; 178:367-372.
15. Jinzaki M, Tanimoto A, Mukai M, et al. Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr 2000; 24:835-842.
16. Kim JK, Kim TK, Ahn HJ, et al. Differentiation of subtypes of renal cell carcinoma on helical CT scans. AJR Am J Roentgenol 2002; 178:1499-1506.
17. Press GA, McClennan BL, Melson GL, et al. Papillary renal cell carcinoma: CT and sonographic evaluation. AJR Am J Roentgenol 1984; 143:1005-1009.
18. Ruppert-Kohlmayr AJ, Uggowitzer M, Meissnitzer T, Ruppert G. Differentiation of renal clear cell carcinoma and renal papillary carcinoma using quantitative CT enhancement parameters. AJR Am J Roentgenol 2004; 183:1387-1391.
19. Sheir KZ, El-Azab M, Mosbah A, et al. Differentiation of renal cell carcinoma subtypes by multislice computerized tomography. J Urol 2005; 174:451-455.
20. Zhang J, Lefkowitz R, Ishill N, et al. Differentiation of solid renal cortical tumors by CT. Radiology 244:494-504. In this study, 90% of clear cell renal carcinomas were hypervascular and demonstrated a heterogeneous enhancing pattern. Seventy-five percent of papillary renal cell carcinomas were hypovascular, and 90% of papillary carcinomas demonstrated either homogeneous or peripheral enhancement. Chromophobe tumors demonstrated moderate vascularity and variable enhancement patterns.
21. Kassouf W, Aprikian AG, Laplante M, Tanguay S. Natural history of renal masses followed expectantly. J Urol 2004; 171:111-113.
22. Volpe A, Panzarella T, Rendon RA, et al. The natural history of incidentally detected small renal masses. Cancer 2004; 100:738-745.
23. Sowery RD, Siemens DR. Growth characteristics of renal cortical tumors in patients managed by watchful waiting. Can J Urol 2004; 11:2407-2410.
24. Ozono S, Miyao N, Igarashi T, et al. Tumor doubling time of renal cell carcinoma measured by CT: collaboration of Japanese Society of Renal Cancer. Jpn J Clin Oncol 2004; 34:82-85.
25. Rendon RA, Stanietzky N, Panzarella T, et al. The natural history of small renal masses. J Urol 2000; 164:1143-1147.
26. Fujimoto N, Sugita A, Terasawa Y, Kato M. Observations on the growth rate of renal cell carcinoma. Int J Urol 1995; 2:71-76.
27. Oda T, Miyao N, Takahashi A, et al. Growth rates of primary and metastatic lesions of renal cell carcinoma. Int J Urol 2001; 8:473-477.
28. Bosniak MA, Birnbaum BA, Krinsky GA, Waisman J. Small renal parenchymal neoplasms: further observations on growth. Radiology 1995; 197:589-597.
29. Gudbjartsson T, Thoroddsen A, Petursdottir V, et al. Effect of incidental detection for survival of patients with renal cell carcinoma: results of population-based study of 701 patients. Urology 2005; 66:1186-1191.
30. Siu W, Hafez KS, Johnston WK 3rd, Wolf JS Jr. Growth rates of renal cell carcinoma and oncocytoma under surveillance are similar. Urol Oncol 2007; 25:115-119. The authors found that while most renal masses grow slowly, some grow quickly, and delayed growth with metastases can occur. They conclude that surveillance for renal masses is an option but must be rigorous and continuous, and is not without risk of progression.
31. Pretorius ES, Wickstrom ML, Siegelman ES. MR imaging of renal neoplasms. Magn Reson Imaging Clin N Am 2000; 8:813-836.
32. Roy C, Sauer B, Lindner V, et al. MR imaging of papillary renal neoplasms: potential application for characterization of small renal masses. Eur Radiol 2007; 17:193-200. This study identified features distinguishing papillary and clear cell renal carcinomas on MRI.
33. Yoshimitsu K, Kakihara D, Irie H, et al. Papillary renal carcinoma: diagnostic approach by chemical shift gradient-echo and echo-planar MR imaging. J Magn Reson Imaging 2006; 23:339-344. This study identified features distinguishing papillary and clear cell renal carcinomas on chemical shift MR sequences.
34. Outwater EK, Bhatia M, Siegelman ES, et al. Lipid in renal clear cell carcinoma: detection on opposed-phase gradient-echo MR images. Radiology 1997; 205:103-107.
35. Israel GM, Hindman N, Hecht E, Krinsky G. The use of opposed-phase chemical shift MRI in the diagnosis of renal angiomyolipomas. AJR Am J Roentgenol 2005; 184:1868-1872.
36. Kim JK, Kim SH, Jang YJ, et al. Renal angiomyolipoma with minimal fat: differentiation from other neoplasms at double-echo chemical shift FLASH MR imaging. Radiology 2006; 239:174-180. This study found that combined biphasic CT and chemical shift MRI could be used to differentiate AML with minimal fat from other renal neoplasms.
37. Kim JK, Park SY, Shon JH, Cho KS. Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT. Radiology 2004; 230:677-684.
38. Raj GV, Bach AM, Iasonos A, et al. Predicting the histology of renal masses using preoperative Doppler ultrasonography. J Urol 2007; 177:53-58. Vascular flow detected by color Doppler ultrasonography is strongly associated with conventional clear cell histology. This study presents a nomogram incorporating vascular flow on color Doppler ultrasonography and clinical parameters for the preoperative characterization of renal lesions.
39. Pallwein L, Mitterberger M, Aigner F, et al. Small renal masses: the value of contrast-enhanced colour Doppler imaging. BJU Int 2007; 99:579-585. This study found that enhanced color Doppler imaging (CDI) is better than unenhanced CDI for detecting tumor vascularity and for discriminating between benign and malignant small renal masses.
40. Ascenti G, Mazziotti S, Zimbaro G, et al. Complex cystic renal masses: characterization with contrast-enhanced US. Radiology 2007; 243:158-165. This study suggested that contrast-enhanced second-harmonic ultrasound is appropriate for renal cyst classification with the Bosniak system.
41. Park BK, Kim B, Kim SH, et al. Assessment of cystic renal masses based on Bosniak classification: comparison of CT and contrast-enhanced US. Eur J Radiol 2007; 61:310-314. This study found that contrast-enhanced US might be better than CT for visualizing the number of septa, the septa or wall thickness, solid components and the enhancement of some renal cystic masses.
42. Dilhuydy MS, Durieux A, Pariente A, et al. PET scans for decision-making in metastatic renal cell carcinoma: a single-institution evaluation. Oncology 2006; 70:339-344. The authors demonstrated that FDG-PET scanning may detect metastatic foci not visualized on conventional imaging and thus influence clinical management in patients with renal cell carcinoma.
43. Divgi CR, Pandit-Taskar N, Jungbluth AA, et al. Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial. Lancet Oncol 2007; 8:304-310. This phase I prospective clinical trial showed that PET with (124)I-cG250 can accurately identify clear-cell renal carcinoma.
44. Beland MD, Mayo-Smith WW, Dupuy DE, et al. Diagnostic yield of 58 consecutive imaging-guided biopsies of solid renal masses: should we biopsy all that are indeterminate? AJR Am J Roentgenol 2007; 188:792-797. The authors demonstrate that because of the advances in biopsy and histology techniques, imaging-guided biopsy can potentially provide accurate preoperative tissue diagnosis in patients with renal masses.
45. Maturen KE, Nghiem HV, Caoili EM, et al. Renal mass core biopsy: accuracy and impact on clinical management. AJR Am J Roentgenol 2007; 188:563-570. This study of 276 imaging-guided percutaneous core needle biopsies of renal masses showed that renal mass biopsy is safe and highly accurate. Tissue diagnosis altered clinical decision making in more than half of the cases.